How many stocks are there of AbbVie?
The current number of stocks of AbbVie is 1.77 B undefined.
AbbVie Stocks 2024
AbbVie Stocks
1.77 B
Ticker
ABBV
ISIN
US00287Y1091
WKN
A1J84E
In 2024, AbbVie had 1.77 B outstanding stocks, a 0% change from the 1.77 B stocks in the previous year.
The AbbVie Stocks history
| YEAR | NUMBER OF STOCKS (undefined USD) |
|---|---|
| 2029e | 1.77 |
| 2028e | 1.77 |
| 2027e | 1.77 |
| 2026e | 1.77 |
| 2025e | 1.77 |
| 2024e | 1.77 |
| 2023 | 1.77 |
| 2022 | 1.78 |
| 2021 | 1.78 |
| 2020 | 1.67 |
| 2019 | 1.48 |
| 2018 | 1.55 |
| 2017 | 1.6 |
| 2016 | 1.63 |
| 2015 | 1.64 |
| 2014 | 1.61 |
| 2013 | 1.6 |
| 2012 | 1.58 |
| 2011 | 1.58 |
| 2010 | 1.58 |
| 2009 | 1.58 |
AbbVie shares outstanding US00287Y1091 · A1J84E
The number of shares was AbbVie in 2023 — This indicates how many shares 1.773 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue AbbVie earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates AbbVie's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of AbbVie’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating AbbVie's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2009 | 1.58 B Aktien |
| 2010 | 1.58 B Aktien |
| 2011 | 1.58 B Aktien |
| 2012 | 1.58 B Aktien |
| 2013 | 1.6 B Aktien |
| 2014 | 1.61 B Aktien |
| 2015 | 1.64 B Aktien |
| 2016 | 1.63 B Aktien |
| 2017 | 1.6 B Aktien |
| 2018 | 1.55 B Aktien |
| 2019 | 1.48 B Aktien |
| 2020 | 1.67 B Aktien |
| 2021 | 1.78 B Aktien |
| 2022 | 1.78 B Aktien |
| 2023 | 1.77 B Aktien |
| 2024e | 1.77 B Aktien |
| 2025e | 1.77 B Aktien |
| 2026e | 1.77 B Aktien |
| 2027e | 1.77 B Aktien |
| 2028e | 1.77 B Aktien |
| 2029e | 1.77 B Aktien |
AbbVie Aktienanalyse
What does AbbVie do?
Abbvie Inc. is a global, research-oriented company specializing in the field of biotechnology and pharmaceuticals. It was founded in 2013 as a spin-off from Abbott Laboratories. Abbvie's headquarters are in North Chicago, Illinois, and it employs over 47,000 people in more than 75 countries worldwide. The company focuses on researching, developing, and marketing high-quality therapies for the treatment of serious and life-threatening diseases. Abbvie has several business divisions, including immunology, oncology, neurology, and virology, and is known for its investments in research and development. Its key products include adalimumab (sold under the brand name Humira) for autoimmune diseases and Imbruvica for chronic lymphocytic leukemia. Abbvie is recognized as a leading company in the biotechnology and pharmaceutical industry due to its focus on innovative therapies and medicines. AbbVie ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating AbbVie's Shares Outstanding
AbbVie's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in AbbVie’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding AbbVie’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in AbbVie’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about AbbVie stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of AbbVie are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of AbbVie evolved in recent years?
The number of shares of AbbVie has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. AbbVie as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of AbbVie?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does AbbVie pay?
Over the past 12 months, AbbVie paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, AbbVie is expected to pay a dividend of 6.04 USD.
What is the dividend yield of AbbVie?
The current dividend yield of AbbVie is .
When does AbbVie pay dividends?
AbbVie pays a quarterly dividend. This is distributed in the months of May, August, November, February.
How secure is the dividend of AbbVie?
AbbVie paid dividends every year for the past 101 years.
What is the dividend of AbbVie?
For the upcoming 12 months, dividends amounting to 6.04 USD are expected. This corresponds to a dividend yield of 3.52 %.
In which sector is AbbVie located?
AbbVie is assigned to the 'Health' sector.
Wann musste ich die Aktien von AbbVie kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of AbbVie from 11/15/2024 amounting to 1.55 USD, you needed to have the stock in your portfolio before the ex-date on 10/15/2024.
When did AbbVie pay the last dividend?
The last dividend was paid out on 11/15/2024.
What was the dividend of AbbVie in the year 2023?
In the year 2023, AbbVie distributed 5.64 USD as dividends.
In which currency does AbbVie pay out the dividend?
The dividends of AbbVie are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The AbbVie stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank
Andere Kennzahlen von AbbVie
Our stock analysis for AbbVie Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of AbbVie Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
